Cervical EVT isolation for non-invasive fetal HLA typing in early pregnancy is limited by purity and maternal cell contamination; a methodological comparison., PMID:40416984
Phase 1 study of IMCnyeso, a T cell receptor bispecific ImmTAC targeting NY-ESO-1-expressing malignancies., PMID:40054461
Influence of HLA-G 3' Untranslated Region Haplotypes and SNP +3422 Gene Variants as Host Genetic Factors on the Outcomes of SARS-CoV-2 Infection During Acute and Post-Acute Phases in a German Cohort., PMID:39711218
Safety and Tolerability of Letetresgene Autoleucel (GSK3377794): Pilot Studies in Patients with Advanced Non-Small Cell Lung Cancer., PMID:39576208
Preclinical and first-in-human evaluation of AL002, a novel TREM2 agonistic antibody for Alzheimer's disease., PMID:39444037
Targeting Dual Immune Checkpoints PD-L1 and HLA-G by Trispecific T Cell Engager for Treating Heterogeneous Lung Cancer., PMID:39234811
Safety and clinical activity of JNJ-78306358, a human leukocyte antigen-G (HLA-G) x CD3 bispecific antibody, for the treatment of advanced stage solid tumors., PMID:39105878
HLA and KIR genetic association and NK cells in anti-NMDAR encephalitis., PMID:39050850
Long-term survival follow-up for tebentafusp in previously treated metastatic uveal melanoma., PMID:38844408
SARS-CoV-2 immune response and reinfection in vaccinated Maya and mestizo in Southeast of Mexico., PMID:38065105
Low Prevalence of HLA-G Antibodies in Lung Transplant Patients Detected using MAIPA-Adapted Protocol., PMID:38003669
T cell receptor therapeutics: immunological targeting of the intracellular cancer proteome., PMID:37891435
Dynamics of Soluble Forms of the Immune Checkpoint Components PD-1/PD-L1/B7-H3, CD314/ULBP1, and HLA-G in Peripheral Blood of Melanoma Patients Receiving Blockers of Programmed Cell Death Protein PD-1., PMID:37773572
Immunotherapies in MuSK-positive Myasthenia Gravis; an IgG4 antibody-mediated disease., PMID:37564637
Co-expression of HLA-E and HLA-G on genetically modified porcine endothelial cells attenuates human NK cell-mediated degranulation., PMID:37529053
Prognostic value of human leukocyte antigen G expression in solid tumors: a systematic review and meta-analysis., PMID:37275862
Antibodies for β2-Microglobulin and the Heavy Chains of HLA-E, HLA-F, and HLA-G Reflect the HLA-Variants on Activated Immune Cells and Phases of Disease Progression in Rheumatoid Arthritis Patients under Treatment., PMID:37092447
Involvement of circulating soluble HLA-G after liver transplantation in the low immunogenicity of hepatic allograft., PMID:36897848
Donor and recipient human leukocyte antigen-G polymorphisms modulate the risk of adverse immunologic events following lung transplantation., PMID:36695689
Histological Characterization of Class I HLA Molecules in Whole Umbilical Cord Tissue Towards an Inexhaustible Graft Alternative for Reconstructive Surgery., PMID:36671682
Combined plasma levels of IL-10 and testosterone, but not soluble HLA-G5, predict the risk of death in COVID-19 patients., PMID:36323494
The double-sided of human leukocyte antigen-G molecules in type 1 autoimmune hepatitis., PMID:36311782
BND-22, a first-in-class humanized ILT2-blocking antibody, promotes antitumor immunity and tumor regression., PMID:36096532
Immunoglobulin-like transcript 2 blockade restores antitumor immune responses in glioblastoma., PMID:36082628
Myelin oligodendrocyte glycoprotein-associated disease is associated with BANK1, RNASET2 and TNIP1 polymorphisms., PMID:36054934
Placental Malaria is Associated with Higher LILRB2 Expression in Monocyte Subsets and Lower Anti-Malarial IgG Antibodies During Infancy., PMID:35911674
HLA-G as a prognostic marker in stage II/III colorectal cancer: not quite there yet., PMID:35902421
Genotyping and evaluation of interleukin-10 and soluble HLA-G in abortion due to toxoplasmosis and HSV-2 infections., PMID:35810388
Epigenetic/genetic variations in CG-rich elements of immune-related genes contribute to food allergy development during childhood., PMID:35754135
Detection of all isoforms of human leukocyte antigen G in maternal serum could be clinically applied for prediction of preeclampsa., PMID:35660512
NKG2A-checkpoint inhibition and its blockade critically depends on peptides presented by its ligand HLA-E., PMID:35596615
The association of decreased HLA-G+ immune cell frequencies with critical COVID-19 patients., PMID:35584714
Impact of HLA-G +3142C>G on the development of antibodies to blood group systems other than the Rh and Kell among sensitized patients with sickle cell disease., PMID:35487873
Mesenchymal stromal cell delivery as a potential therapeutic strategy against COVID-19: Promising evidence from in vitro results., PMID:35432769
HLA-G and Other Immune Checkpoint Molecules as Targets for Novel Combined Immunotherapies., PMID:35328349
HLA-G-ILT2 interaction contributes to suppression of bone marrow B cell proliferation in acquired aplastic anemia., PMID:35041051
The Different Immune Responses by Age Are due to the Ability of the Fetal Immune System to Secrete Primal Immunoglobulins Responding to Unexperienced Antigens., PMID:35002513
Perspective of HLA-G Induced Immunosuppression in SARS-CoV-2 Infection., PMID:34938296
HLA-G/sHLA-G and HLA-G-Bearing Extracellular Vesicles in Cancers: Potential Role as Biomarkers., PMID:34868081
HLA-G gene editing in tumor cell lines as a novel alternative in cancer immunotherapy., PMID:34773056
Altered Frequency and Phenotype of HLA-G-Expressing DC-10 in Type 1 Diabetes Patients at Onset and in Subjects at Risk to Develop the Disease., PMID:34659254
Clinical Outcome of Kidney Transplant Patients on the Allograft Function, Loss, Effects of HLA-DQB1-DSA+, and Graft Survival., PMID:34420780
Relation between anti-Porphyromonas gingivalis antibody titers and HLA-DRB1 neutral alleles in individuals with rheumatoid arthritis., PMID:34379040
Suppressor CD4+ T cells expressing HLA-G are expanded in the peripheral blood from patients with acute decompensation of cirrhosis., PMID:34344786
Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study., PMID:34339623
HLA-G/ILTs Targeted Solid Cancer Immunotherapy: Opportunities and Challenges., PMID:34276691
Tumor infiltrating and peripheral CD4+ILT2+ T cells are a cytotoxic subset selectively inhibited by HLA-G in clear cell renal cell carcinoma patients., PMID:34186161
Interaction between HLA-G and NK cell receptor KIR2DL4 orchestrates HER2-positive breast cancer resistance to trastuzumab., PMID:34158475
Intrinsic Resistance of Chronic Lymphocytic Leukemia Cells to NK Cell-Mediated Lysis Can Be Overcome In Vitro by Pharmacological Inhibition of Cdc42-Induced Actin Cytoskeleton Remodeling., PMID:34108958
Prognostic and Clinicopathological Value of Human Leukocyte Antigen G in Gastrointestinal Cancers: A Meta-Analysis., PMID:34055611
For research use only. Not for human or drug use.
